Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER.

Di X, Shi X, Gai F, Wang J

Open source

DOI
10.3389/fonc.2025.1621045
Published
2025
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1621045,
  title = {Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER.},
  author = {Di X and Shi X and Gai F and Wang J},
  year = {2025},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2025.1621045},
  url = {https://doi.org/10.3389/fonc.2025.1621045}
}

RIS

TY  - JOUR
TI  - Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER.
AU  - Di X
AU  - Shi X
AU  - Gai F
AU  - Wang J
PY  - 2025
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2025.1621045
UR  - https://doi.org/10.3389/fonc.2025.1621045
ER  - 

APA

X, D., X, S., F, G., & J, W. (2025). Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER.. Frontiers in oncology. https://doi.org/10.3389/fonc.2025.1621045

Source records